Page 338 - Concise Pathology for Exam Preparation ( PDFDrive )
P. 338

12  Haematology  323


               2.  World Health Organization (WHO) classification of acute leukaemias
               Blast count for diagnosis of acute leukaemia . or 5 20% in peripheral blood or bone
                 marrow (in FAB classification the cut off is 30%; it has been demonstrated that
                 the survival pattern of patients with 20–30% blasts is similar to those with a count
                 of .30%).
             WHO	classification	of	AML
             •  AML with recurrent genetic abnormalities
               •  AML with t(8; 21) (q22; q22); AML1/ETO
               •  AML with abnormal bone marrow eosinophils inv(16)(p13; q22) or t(16; 16)(p13;
                 q22); (CBFb/MYH11)
               •  Acute promyelocytic leukaemia AML with t(15; 17)(q22; q12)(PML/RARa) and variants
               •  AML with 11q23(MLL) abnormalities
             •  AML with multilineage dysplasia
               •  Following a myelodysplastic syndrome
               •  Without antecedent myelodysplastic syndrome
             •  AML and myelodysplastic syndromes, therapy related
               •  Alkylating agent related
               •  Topoisomerase Type II inhibitor related
               •  Other types
             •  AML not otherwise characterized/specified
               •  AML minimally differentiated
               •  AML without maturation
               •  AML with maturation
               •  Acute myelomonocytic leukaemia
               •  Acute monoblastic and monocytic leukaemia
               •  Acute erythroid leukaemia
               •  Acute megakaryoblastic leukaemia
               •  Acute basophilic leukaemia
               •  Acute pan myelosis with myelofibrosis
               •  Myeloid sarcoma
               •  Myeloid proliferations related to Down’s syndrome
               •  Blastic plasmacytoid dendritic cell neoplasms
             Classification	of	ALL (Table 12.13)



                  TABLE 12.13.    Classification of ALL
                  WHO type                                 FAB correlation
                  Precursor B lymphoblastic leukaemia/lymphoma  L1 and L2
                  Precursor T lymphoblastic leukaemia/lymphoma  L1 and L2
                  Leukemic phase of Burkitt lymphoma       L3




             Q. Write briefly on the aetiopathogenesis of leukaemias.
             Ans. The factors contributing to the etiopathogenesis of leukemias are:
             •  Familial  and  genetic:  Down  syndrome,  ataxia  telangiectasia,  Fanconi  anaemia  and
               Bloom syndrome
             •  Drugs and toxins: Cytotoxic drugs like alkylating agents and exposure to benzene
             •  Retroviruses:  Human  T-cell  leukaemia-lymphoma  virus  (human  T-cell  lymphotropic
               Type I virus)
             •  Ionizing radiation: Therapeutic irradiation, diagnostic X-rays and nuclear bombs
             •  Immunological: Immunodeficiency states






                                  mebooksfree.com
   333   334   335   336   337   338   339   340   341   342   343